title: Vitamin D Receptor Genetic Polymorphisms and Prostate Cancer Risk: A Meta-analysis of 36 Published Studies.
abstract: To update data on the role of vitamin D receptor (VDR) single nucleotide polymorphisms (SNPs) in susceptibility to prostate cancer, we performed a meta-analysis of 36 eligible publications on the association of Taql, Apal, Bsml, Fokl and CDX2 SNPs of the VDR gene with prostate cancer risk. Our study suggested that the Taql t and Bsml B alleles were associated with reduced prostate cancer risk among all study populations. Stratified analysis by ethnicity revealed that the Apal a allele was associated with reduced prostate cancer risk only among Asian populations, whereas the Fokl f allele showed a trend of increased prostate cancer risk only among Caucasian populations in a dominant model, independent of tumor stage (local or advanced). These results suggest that VDR polymorphisms may be potential biomarkers for prostate cancer susceptibility.
authors.affiliation: Departments of Epidemiology, The University of Texas, M. D. Anderson Cancer Center 1515 Holcombe Blvd, Houston, TX77030, USA.
authors.forename: Ming
authors.initials: M
authors.lastname: Yin
authors.forename: Sheng
authors.initials: S
authors.lastname: Wei
authors.forename: Qingyi
authors.initials: Q
authors.lastname: Wei
references.citation: Urol Clin North Am. 2003 May;30(2):209-17
references.pmid: 12735498
references.citation: Eur Urol. 2000 Feb;37(2):234-8
references.pmid: 10705205
references.citation: Asian Pac J Cancer Prev. 2006 Jan-Mar;7(1):136-9
references.pmid: 16629532
references.citation: Exp Biol Med (Maywood). 2008 Dec;233(12):1608-14
references.pmid: 18849534
references.citation: J Bone Miner Res. 1996 Dec;11(12):1850-5
references.pmid: 8970885
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9
references.pmid: 17932346
references.citation: Urol Int. 2002;68(4):226-31
references.pmid: 12053022
references.citation: J Urol. 2006 May;175(5):1613-23
references.pmid: 16600714
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Oncogene. 2000 Oct 19;19(44):5091-7
references.pmid: 11042697
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):997-9
references.pmid: 15824177
references.citation: Carcinogenesis. 2001 Sep;22(9):1343-7
references.pmid: 11532853
references.citation: Int J Biol Markers. 2004 Jul-Sep;19(3):245-9
references.pmid: 15503828
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Ann Intern Med. 1997 Nov 1;127(9):820-6
references.pmid: 9382404
references.citation: PLoS Med. 2007 Mar;4(3):e103
references.pmid: 17388667
references.citation: Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):467-72
references.pmid: 8220092
references.citation: J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):221-5
references.pmid: 15225775
references.citation: Mol Cell Endocrinol. 2001 May 25;177(1-2):145-59
references.pmid: 11377830
references.citation: Cancer Lett. 2004 Apr 15;207(1):69-77
references.pmid: 15050735
references.citation: Cancer Res. 2000 Jan 15;60(2):305-8
references.pmid: 10667581
references.citation: Saudi Med J. 2004 Apr;25(4):447-51
references.pmid: 15083213
references.citation: Oncology. 2006;71(1-2):111-23
references.pmid: 17377416
references.citation: Eur J Cancer. 2009 Mar;45(4):634-41
references.pmid: 19008093
references.citation: Am J Clin Nutr. 2008 Aug;88(2):565S-569S
references.pmid: 18689403
references.citation: Biometrics. 2000 Jun;56(2):455-63
references.pmid: 10877304
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90
references.pmid: 9610787
references.citation: Mol Endocrinol. 1997 Jul;11(8):1165-79
references.pmid: 9212063
references.citation: J Urol. 1998 Oct;160(4):1405-9
references.pmid: 9751364
references.citation: Cancer Res. 2005 Jun 15;65(12):5470-9
references.pmid: 15958597
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1429-37
references.pmid: 14693733
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: N Engl J Med. 1992 Jul 23;327(4):248-54
references.pmid: 1614465
references.citation: J Natl Cancer Inst. 2008 Jun 4;100(11):796-804
references.pmid: 18505967
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2549-52
references.pmid: 17164384
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10529-34
references.pmid: 9724737
references.citation: Cancer Res. 1992 Feb 1;52(3):515-20
references.pmid: 1370648
references.citation: Nature. 1994 Jan 20;367(6460):284-7
references.pmid: 8161378
references.citation: Endocrinology. 1993 May;132(5):1952-60
references.pmid: 7682937
references.citation: Endocr J. 1999 Jun;46(3):467-70
references.pmid: 10504001
references.citation: Int J Urol. 2003 May;10(5):261-6
references.pmid: 12694466
references.citation: Cancer. 1992 Dec 15;70(12):2861-9
references.pmid: 1451068
references.citation: Prostate. 2007 Jun 15;67(9):911-23
references.pmid: 17440943
references.citation: Mol Carcinog. 2000 Jan;27(1):18-23
references.pmid: 10642433
references.citation: Cancer Res. 1994 Feb 1;54(3):805-10
references.pmid: 7508338
references.citation: Clin Cancer Res. 2008 May 15;14(10):3223-9
references.pmid: 18483391
references.citation: J Bone Miner Res. 1998 Nov;13(11):1691-9
references.pmid: 9797477
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1395-402
references.pmid: 14693728
references.citation: J Biol Chem. 2004 Apr 16;279(16):16754-66
references.pmid: 14739296
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1325-30
references.pmid: 15298953
references.citation: Anticancer Res. 1999 Sep-Oct;19(5C):4511-4
references.pmid: 10650802
references.citation: Acta Oncol. 2005;44(3):277-81
references.pmid: 16076700
references.citation: Hum Genet. 1999 Sep;105(3):281-7
references.pmid: 10987658
references.citation: Prostate. 2004 Jun 1;59(4):409-18
references.pmid: 15065089
references.citation: Urology. 2001 Mar;57(3):567-72
references.pmid: 11248649
references.citation: Cancer Res. 1998 Apr 15;58(8):1620-3
references.pmid: 9563471
references.citation: J Bone Miner Res. 2001 Jul;16(7):1256-64
references.pmid: 11450701